Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.76
-0.7%
$103.93
$81.97
▼
$132.02
$186.77B0.5411.08 million shs4.68 million shs
Citigroup Inc. stock logo
C
Citigroup
$120.85
-2.6%
$127.87
$95.83
▼
$147.96
$206.14B1.1812.11 million shs4.26 million shs
The Trade Desk stock logo
TTD
Trade Desk
$14.80
-5.6%
$13.20
$11.62
▼
$41.91
$6.94B0.9820.42 million shs12.33 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.30%+3.63%-1.88%-16.84%
Citigroup Inc. stock logo
C
Citigroup
0.00%+4.10%-0.26%-10.44%+23.75%
The Trade Desk stock logo
TTD
Trade Desk
0.00%+21.27%+28.21%+17.01%-62.60%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.76
-0.7%
$103.93
$81.97
▼
$132.02
$186.77B0.5411.08 million shs4.68 million shs
Citigroup Inc. stock logo
C
Citigroup
$120.85
-2.6%
$127.87
$95.83
▼
$147.96
$206.14B1.1812.11 million shs4.26 million shs
The Trade Desk stock logo
TTD
Trade Desk
$14.80
-5.6%
$13.20
$11.62
▼
$41.91
$6.94B0.9820.42 million shs12.33 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.30%+3.63%-1.88%-16.84%
Citigroup Inc. stock logo
C
Citigroup
0.00%+4.10%-0.26%-10.44%+23.75%
The Trade Desk stock logo
TTD
Trade Desk
0.00%+21.27%+28.21%+17.01%-62.60%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.89
Moderate Buy$118.329.80% Upside
Citigroup Inc. stock logo
C
Citigroup
2.89
Moderate Buy$150.8724.84% Upside
The Trade Desk stock logo
TTD
Trade Desk
1.87
Reduce$18.5225.12% Upside

Current Analyst Ratings Breakdown

Latest ABT, C, and TTD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/11/2026
The Trade Desk stock logo
TTD
Trade Desk
Boost Price TargetEqual Weight$12.00 ➝ $15.00
11/11/2026
The Trade Desk stock logo
TTD
Trade Desk
Boost Price TargetNeutral$14.00 ➝ $16.00
11/11/2026
The Trade Desk stock logo
TTD
Trade Desk
Boost Price TargetNeutral$14.00 ➝ $15.00
11/10/2026
The Trade Desk stock logo
TTD
Trade Desk
Reiterated RatingBuy$15.00 ➝ $19.00
11/10/2026
The Trade Desk stock logo
TTD
Trade Desk
Reiterated RatingNeutral$14.00 ➝ $17.00
11/10/2026
The Trade Desk stock logo
TTD
Trade Desk
Set Price TargetHold$16.00 ➝ $17.00
11/10/2026
The Trade Desk stock logo
TTD
Trade Desk
Reiterated RatingSector Weight
11/10/2026
The Trade Desk stock logo
TTD
Trade Desk
Initiated CoverageNeutral
11/10/2026
The Trade Desk stock logo
TTD
Trade Desk
Boost Price TargetSell$11.00 ➝ $12.00
11/10/2026
The Trade Desk stock logo
TTD
Trade Desk
Boost Price TargetEqual Weight$13.00 ➝ $14.00
10/30/2026
Citigroup Inc. stock logo
C
Citigroup
Boost Price TargetOverweight$147.00 ➝ $148.50
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$48.23B3.87$6.94 per share15.52$30.35 per share3.55
Citigroup Inc. stock logo
C
Citigroup
$93.12B2.21$11.58 per share10.44$108.30 per share1.12
The Trade Desk stock logo
TTD
Trade Desk
$2.90B2.40$1.11 per share13.35$5.22 per share2.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$2.6840.2418.201.909.75%18.04%9.09%1/28/2027 (Estimated)
Citigroup Inc. stock logo
C
Citigroup
$14.31B$10.2511.799.220.5410.97%10.57%0.73%1/14/2027 (Estimated)
The Trade Desk stock logo
TTD
Trade Desk
$443.30M$0.6921.4037.952.1611.03%14.36%6.21%N/A

Latest ABT, C, and TTD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
The Trade Desk stock logo
TTD
Trade Desk
$0.0374$0.33+$0.2927$0.08$650.93 million$735.97 million
10/21/2026Q3 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.42$1.42N/A$0.53$12.99 billion$13.01 billion
10/13/2026Q3 2026
Citigroup Inc. stock logo
C
Citigroup
$2.66$2.85+$0.19$2.85$23.74 billion$23.85 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.34%+10.39%94.03%54 Years
Citigroup Inc. stock logo
C
Citigroup
$2.682.22%+2.61%26.15%2 Years
The Trade Desk stock logo
TTD
Trade Desk
N/AN/AN/AN/AN/A

Latest ABT, C, and TTD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/19/2026
Citigroup Inc. stock logo
C
Citigroup
quarterly$0.672.18%11/2/202611/2/202611/25/2026
9/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.4%10/15/202610/15/202611/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.57
1.45
1.00
Citigroup Inc. stock logo
C
Citigroup
1.78
1.00
1.00
The Trade Desk stock logo
TTD
Trade Desk
N/A
1.79
1.79

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Citigroup Inc. stock logo
C
Citigroup
71.72%
The Trade Desk stock logo
TTD
Trade Desk
67.77%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Citigroup Inc. stock logo
C
Citigroup
0.11%
The Trade Desk stock logo
TTD
Trade Desk
11.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.72 billionOptionable
Citigroup Inc. stock logo
C
Citigroup
226,0001.71 billion1.70 billionOptionable
The Trade Desk stock logo
TTD
Trade Desk
3,843469.88 million414.81 millionOptionable

Recent News About These Companies

Wall Street Zen Upgrades Trade Desk (NASDAQ:TTD) to "Hold"
Trade Desk (NASDAQ:TTD) Price Target Raised to $16.00
The Trade Desk: A Short Squeeze In The Making
Finally! Great News for The Trade Desk Stock Investors
Piper Sandler Keeps Their Hold Rating on Trade Desk (TTD)
Has Trade Desk Stock Become A Different Bet?
Wedbush Reaffirms "Neutral" Rating for Trade Desk (NASDAQ:TTD)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$107.76 -0.76 (-0.70%)
As of 03:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Citigroup stock logo

Citigroup NYSE:C

$120.85 -3.16 (-2.55%)
As of 03:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Citigroup Inc., a diversified financial service holding company, provides various financial product and services to consumers, corporations, governments, and institutions worldwide. It operates through five segments: Services, Markets, Banking, U.S. Personal Banking, and Wealth. The Services segment includes Treasury and Trade Solutions, which provides cash management, trade, and working capital solutions to multinational corporations, financial institutions, and public sector organizations; and Securities Services, such as cross-border support for clients, local market expertise, post-trade technologies, data solutions, and various securities services solutions. The Markets segment offers sales and trading services for equities, foreign exchange, rates, spread products, and commodities to corporate, institutional, and public sector clients; and market-making services, including asset classes, risk management solutions, financing, prime brokerage, research, securities clearing, and settlement. The banking segment includes investment banking; advisory services related to mergers and acquisitions, divestitures, restructurings, and corporate defense activities; and corporate lending, which includes corporate and commercial banking. The U.S. Personal Banking segment provides co-branded cards and retail banking services. The Wealth segment provides financial services to high-net-worth clients through banking, lending, mortgages, investment, custody, and trust product offerings; and to professional industries, including law firms, consulting groups, accounting, and asset management. The company was founded in 1812 and is headquartered in New York, New York.

Trade Desk stock logo

Trade Desk NASDAQ:TTD

$14.80 -0.88 (-5.61%)
As of 03:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.

The Trade Desk, Inc. operates as a technology company in the United States and internationally. The company offers a self-service cloud-based platform that allows buyers to plan, manage, optimize, and measure data-driven digital advertising campaigns across various ad formats and channels, including video, display, audio, digital-out-of-home, native, and social on various devices, such as computers, mobile devices, televisions, and streaming devices. It provides data and other value-added services. The company serves advertising agencies, brands, and other service providers for advertisers. The Trade Desk, Inc. was incorporated in 2009 and is headquartered in Ventura, California.